InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Thomson Peter G., Vice-Président Finance et Comptabilité. Director active across 1 companies, notably Fulcrum Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €35k. The latest transaction was disclosed on 28 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€17,3532,300 shares@ €7.54470.0039% mcap100.0% of flow
Common Stock
SEC:0000899243-21-026555·
Ideal exit: 25 Mar 2022 (T+270)
€17,3532,300 shares@ €7.54470.0039% mcap50.0% of flow
Common Stock
SEC:0000899243-21-026555:0·
Ideal exit: 25 Mar 2022 (T+270)
2 of 2 declarations
About Thomson Peter G.
Thomson Peter G. is the Vice President of Finance and Accounting at Fulcrum Therapeutics, Inc. In this role, he is responsible for the financial management and accounting of the company. He oversees financial reporting, budgeting, and regulatory compliance. His expertise in finance is essential to support the company's growth strategy and ensure effective management of financial resources.
